Cargando…

Time to knock monoclonal antibodies off the platform for patients hospitalised with COVID-19

Detalles Bibliográficos
Autores principales:	Shapiro, Adrienne E, Bender Ignacio, Rachel A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700277/ https://www.ncbi.nlm.nih.gov/pubmed/34953521 http://dx.doi.org/10.1016/S1473-3099(21)00762-3

Ejemplares similares

Monoclonals for patients hospitalised with COVID-19
por: Pogue, Jason M, et al.
Publicado: (2022)

COVID-19 and involuntary hospitalisation: navigating the challenge
por: Gold, Azgad, et al.
Publicado: (2020)

Convalescent plasma in patients hospitalised with COVID-19
por: Liu, Sean T H, et al.
Publicado: (2021)

Antiviral monotherapy for hospitalised patients with COVID-19 is not enough
por: Cao, Bin, et al.
Publicado: (2020)

Dexamethasone in hospitalised patients with COVID-19: addressing uncertainties
por: Matthay, Michael A, et al.
Publicado: (2020)

Hospitalisation among vaccine breakthrough COVID-19 infections
por: Juthani, Prerak V, et al.
Publicado: (2021)

Baricitinib as the treatment of choice for hospitalised individuals with COVID-19
por: Richardson, Peter J., et al.
Publicado: (2022)

COVID-19 outbreak and decreased hospitalisation of pregnant women in labour
por: Kumari, Vimla, et al.
Publicado: (2020)

Renin-angiotensin system inhibitors in hospitalised patients with COVID-19
por: Williams, Bryan
Publicado: (2021)

Early oral antiviral use in patients hospitalised with COVID-19
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2022)

Developing therapeutic monoclonal antibodies at pandemic pace
por: Kelley, Brian
Publicado: (2020)

Alternatives to conventional hospitalisation that enhance health systems' capacity to treat COVID-19
por: Nicolás, David, et al.
Publicado: (2021)

High-dose immunoglobulins from convalescent donors for patients hospitalised with COVID-19
por: So-Osman, Cynthia, et al.
Publicado: (2022)

Knocking down the obstacles to functional genomics data sharing
por: Simpson, Kaylene J., et al.
Publicado: (2017)

Off-label therapy targeting pathogenic inflammation in COVID-19
por: Romani, Luigina, et al.
Publicado: (2020)

Evaluating interest in off-label use of disinfectants for COVID-19
por: Rivera, Jessica Malaty, et al.
Publicado: (2020)

Protecting intubated patients from the threat of antimicrobial resistant infections with monoclonal antibodies
por: Baker, Stephen, et al.
Publicado: (2020)

Predicted COVID-19 positive cases, hospitalisations, and deaths associated with the Delta variant of concern, June–July, 2021
por: Shah, Syed Ahmar, et al.
Publicado: (2021)

Effectiveness of the COVID-19 vaccines against hospitalisation with Omicron sub-lineages BA.4 and BA.5 in England
por: Møller Kirsebom, Freja Cordelia, et al.
Publicado: (2022)

PRINCIPLE: a community-based COVID-19 platform trial
por: Macleod, John, et al.
Publicado: (2021)

Passive antibody therapy in COVID-19
por: Abraham, Jonathan
Publicado: (2020)

The incidence of Coronavirus disease 2019 (COVID-19) among vaccinated healthcare workers (HCWs): evidence for protection from hospitalisation from an Indonesian cohort
por: Kozlakidis, Zisis
Publicado: (2023)

Protection against COVID-19: beyond antibodies
por: Lacerda, Marcus Vinícius Guimarães, et al.
Publicado: (2022)

Type I interferon, anti-interferon antibodies, and COVID-19
por: Calabrese, Leonard H, et al.
Publicado: (2021)

Vaccination prevents hospitalisations of children and adolescents. A real-world analysis
por: Bolcatto, Pablo G.
Publicado: (2022)

Triage in the time of COVID-19
por: Gilbert, Allison, et al.
Publicado: (2022)

Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases
por: Goulenok, Tiphaine, et al.
Publicado: (2022)

COVID-19 vaccines: neutralizing antibodies and the alum advantage
por: Hotez, Peter J., et al.
Publicado: (2020)

The potential danger of suboptimal antibody responses in COVID-19
por: Iwasaki, Akiko, et al.
Publicado: (2020)

Counting stillbirths and COVID 19—there has never been a more urgent time
por: Homer, Caroline S E, et al.
Publicado: (2021)

No time for complacency on COVID-19 in Europe
por: Flahault, Antoine, et al.
Publicado: (2023)

Do cross-reactive antibodies cause neuropathology in COVID-19?
por: Kreye, Jakob, et al.
Publicado: (2020)

The antibody response of haematological malignancies to COVID-19 infection and vaccination
por: Seebacher, Nicole A.
Publicado: (2022)

SARS-CoV-2 spread and hospitalisations in paediatric patients during the omicron surge
por: Belay, Ermias D, et al.
Publicado: (2022)

Knocking out consumer concerns and regulator’s rules: efficient use of CRISPR/Cas ribonucleoprotein complexes for genome editing in cereals
por: Wolter, Felix, et al.
Publicado: (2017)

Not just antibodies: B cells and T cells mediate immunity to COVID-19
por: Cox, Rebecca J., et al.
Publicado: (2020)

The time to do serosurveys for COVID-19 is now
por: Peeling, Rosanna W, et al.
Publicado: (2020)

Offline: Health in the unhappy time of COVID-19
por: Horton, Richard
Publicado: (2020)

Young people's mental health during the COVID-19 pandemic
por: Creswell, Cathy, et al.
Publicado: (2021)

The new platforms of health care
por: Dorsey, E. Ray
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gjvgtigudu2iqv5eq9am8hm2bl